Skip to content
10-Q

Quarterly Report

EMERGE HEALTH INTERNATIONAL INC

0001477932-19-003070

← back to feed
Filed
May 21, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Mar 12, 2019 17.77M sh
Cash And Equivalents Q2 2018 · Dec 31, 2017 $71.22K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $67.85K
Cash And Equivalents Q2 2018 · Dec 31, 2016 $113.66K
Cash And Equivalents Q2 2018 · Jun 30, 2016 $91.31K
Current Liabilities Q2 2018 · Dec 31, 2017 $289.5K
Current Liabilities Q2 2018 · Jun 30, 2017 $279.01K
Total Liabilities Q2 2018 · Dec 31, 2017 $313.03K
Total Liabilities Q2 2018 · Jun 30, 2017 $293.72K
Current Assets Q2 2018 · Dec 31, 2017 $687.52K
Current Assets Q2 2018 · Jun 30, 2017 $784.9K
Total Assets Q2 2018 · Dec 31, 2017 $1.14M
Total Assets Q2 2018 · Jun 30, 2017 $1.25M
Rd Expense Q2 2018 · Dec 31, 2017 $0
Rd Expense Q2 2018 · Dec 31, 2015 $1.5K
Capex Q2 2018 · Dec 31, 2016 $25.94K
Eps Basic Q2 2018 · Dec 31, 2016 $0.00
Eps Basic Q2 2018 · Dec 31, 2016 −$0.01
Net Income Q2 2018 · Dec 31, 2016 −$75.32K
Net Income Q2 2018 · Dec 31, 2016 −$145.47K
Operating Income Q2 2018 · Dec 31, 2016 −$70.93K
Operating Income Q2 2018 · Dec 31, 2016 −$164.42K
Gross Profit Q2 2018 · Dec 31, 2016 $191.7K
Gross Profit Q2 2018 · Dec 31, 2016 $383.61K
Cost Of Revenue Q2 2018 · Dec 31, 2016 $317.66K
Cost Of Revenue Q2 2018 · Dec 31, 2016 $651.26K
Revenue Q2 2018 · Dec 31, 2016 $509.36K
Revenue Q2 2018 · Dec 31, 2016 $1.03M